T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.87% |
| 2 | Financials | 13.64% |
| 3 | Consumer Discretionary | 13.54% |
| 4 | Industrials | 10.67% |
| 5 | Technology | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VER
1576
DELISTED
VEREIT, Inc.
VER
| $2.07M | ﹤0.01% |
50,887
| – | – |
|
1577
Raymond James Financial
RJF
$34.8B
| $2.04M | ﹤0.01% |
51,423
+7,504
| +17% | +$292K |
|
|
FLG
1578
Flagstar Bank National Association
FLG
$5.92B
| $2.04M | ﹤0.01% |
36,995
+530
| +1% | +$27.9K |
|
1579
Brookdale Senior Living
BKD
$3B
| $2.04M | ﹤0.01% |
58,775
+71
| +0.1% | +$2.62K |
|
1580
VEON
VEON
$3.93B
| $2.02M | ﹤0.01% |
16,241
+2,237
| +16% | +$317K |
|
|
CYBE
1581
DELISTED
Cyberoptics Corp
CYBE
| $2.01M | ﹤0.01% |
199,172
-80,258
| -29% | -$841K |
|
1582
Brown-Forman Class A
BF.A
$13.1B
| $2.01M | ﹤0.01% |
45,000
| – | – |
|
|
BRCD
1583
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $1.99M | ﹤0.01% |
167,489
+883
| +0.5% | +$10.7K |
|
1584
AXIS Capital
AXS
$7.3B
| $1.99M | ﹤0.01% |
37,200
| – | – |
|
|
AMJ
1585
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $1.98M | ﹤0.01% |
49,900
| – | – |
|
1586
NVR
NVR
$17B
| $1.97M | ﹤0.01% |
1,473
| – | – |
|
1587
Madison Square Garden
MSGS
$9.94B
| $1.95M | ﹤0.01% |
32,756
-210,436
| -87% | -$12.6M |
|
1588
Ubiquiti
UI
$35.3B
| $1.95M | ﹤0.01% |
61,000
-70,100
| -53% | -$2.16M |
|
1589
Canadian National Railway
CNI
$77.2B
| $1.94M | ﹤0.01% |
33,520
| – | – |
|
1590
Zebra Technologies
ZBRA
$18B
| $1.93M | ﹤0.01% |
17,392
+800
| +5% | +$83K |
|
|
FMI
1591
DELISTED
Foundation Medicine, Inc.
FMI
| $1.91M | ﹤0.01% |
+56,567
| New | +$2.28M |
|
1592
Alliant Energy
LNT
$18.2B
| $1.91M | ﹤0.01% |
66,096
| – | – |
|
|
GCI
1593
DELISTED
Gannett Co., Inc
GCI
| $1.89M | ﹤0.01% |
+135,041
| New | +$1.92M |
|
1594
Carlisle Companies
CSL
$14.9B
| $1.89M | ﹤0.01% |
18,844
| – | – |
|
1595
AMC Global Media
AMCX
$496M
| $1.89M | ﹤0.01% |
23,025
+910
| +4% | +$70.8K |
|
1596
Sonoco
SON
$5.77B
| $1.86M | ﹤0.01% |
43,487
+3,550
| +9% | +$160K |
|
|
WR
1597
DELISTED
Westar Energy Inc
WR
| $1.84M | ﹤0.01% |
53,850
| – | – |
|
|
BEAV
1598
DELISTED
B/E Aerospace Inc
BEAV
| $1.83M | ﹤0.01% |
33,258
| – | – |
|
1599
Avnet
AVT
$7.87B
| $1.82M | ﹤0.01% |
44,298
-2,500
| -5% | -$110K |
|
|
ACHN
1600
DELISTED
Achillion Pharmaceuticals
ACHN
| $1.8M | ﹤0.01% |
+203,503
| New | +$1.92M |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.